InvestorsHub Logo
Followers 3
Posts 210
Boards Moderated 0
Alias Born 06/03/2020

Re: None

Monday, 04/04/2022 9:29:45 AM

Monday, April 04, 2022 9:29:45 AM

Post# of 43835
Just a reminder about the BioTech CEO interview from last September in which Geert Kersten talks about Multikine:

"We figured we could make at least 12,000 or 13,000 treatments a year. And we looked at it in terms of dollars, that's close to two billion dollars. Guys, we have the existing facility. So what we have is we have created a drug, the likes of which never the world has never seen. It should become part of the standard of care, one of the two arms of head and neck cancer. That's 210,000 people. No safety issues. It's a big deal. We've done a ten year study, that’s the largest ever in head and neck cancer, one of the biggest cancers in the world. We're the first in the world to show benefit from using a cancer drug before surgery and radiation. We built our manufacturing facility before phase 3 and doubled its capacity over the past year."

"It is becoming clear to me that there are financial reasons for others that just don't want us to succeed. The concept of a new, non-toxic cancer drug is something no one has done before. We believe it's all about helping people, and we believe that the FDA will see it the same way."

https://biotechhealthx.com/biotech-ceo-interviews/exclusive-cel-sci-ceo-geert-kersten-talks-multikine-fda-approval-cvm-future/

Tick tock, tick tock...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News